Poly(ADP-ribose) Polymerase Inhibitor Combinations in First-Line Metastatic Castration-Resistant Prostate Cancer: Increasing Toxicity With Unclear Benefits.
Ravi A MadanFatima KarzaiDavid J VanderWeeleHeather H ChengJohann S de BonoPublished in: Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)